Why Penumbra CEO Adam Elsesser will take uncertainty over risk in MedTech innovation

In this episode of the DeviceTalks Weekly Podcast, we’ll play the interview Host Tom Salemi conducted with Adam Elsesser, CEO of Penumbra, which has grown into a force in the vascular and neurovascular industries.

Elsesser’s path into running a MedTech startup was quite accidental, but that unorthodox path has helped the company develop a unique culture for innovation. Elsesser shares that philosophy in this interview and explains why he prefers uncertainty over risk.

Kicking off the episode Jim Hammerand, managing editor of Medical Design and Outsourcing, visits with Chris Newmarker and Salemi to share the highlights of the magazine’s leadership issue including an in-depth interview he did with former Edwards Lifesciences CEO Mike Mussallem.

The three then run through this week’s Newmarker’s Newsmakers – Integra, Olympus, Johnson & Johnson, Boston Scientific, Stryker, and Inari.

Go to DeviceTalks.com to register for our conferences and digital events.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.